Healthcare provider profile · identity verified

Daniel Novella, M.D.

Family Practice · AURORA, IL · NPI 1366670846

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1261	399
Lisinopril	Lisinopril	696	217
Tamsulosin Hcl	Tamsulosin Hcl	442	151
Rosuvastatin Calcium	Rosuvastatin Calcium	425	155
Metformin Hcl	Metformin Hcl	342	112
Famotidine	Famotidine	312	114
Losartan Potassium	Losartan Potassium	312	103
Amlodipine Besylate	Amlodipine Besylate	311	102
Jardiance	Empagliflozin	298	92
Metformin Hcl Er	Metformin Hcl	248	74
Gabapentin	Gabapentin	244	102
Hydrochlorothiazide	Hydrochlorothiazide	242	78
Metoprolol Succinate	Metoprolol Succinate	225	83
Omeprazole	Omeprazole	225	91
Glipizide Er	Glipizide	218	67
Levothyroxine Sodium	Levothyroxine Sodium	201	57
Furosemide	Furosemide	195	74
Carvedilol	Carvedilol	170	65
Fluticasone Propionate	Fluticasone Propionate	147	73
Albuterol Sulfate Hfa	Albuterol Sulfate	144	73
Pioglitazone Hcl	Pioglitazone Hcl	143	44
Naproxen	Naproxen	136	76
Escitalopram Oxalate	Escitalopram Oxalate	126	38
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	117	43
Fenofibrate	Fenofibrate Nanocrystallized	109	36
Pantoprazole Sodium	Pantoprazole Sodium	108	46
Ozempic	Semaglutide	107	26
Spironolactone	Spironolactone	104	40
Allopurinol	Allopurinol	103	29
Finasteride	Finasteride	98	41
Alendronate Sodium	Alendronate Sodium	92	28
Ezetimibe	Ezetimibe	86	31
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	85	37
Sertraline Hcl	Sertraline Hcl	85	31
Alcohol Prep Pads	Alcohol Antiseptic Pads	81	63
Nifedipine Er	Nifedipine	80	24
Buspirone Hcl	Buspirone Hcl	74	23
Dropsafe Prep Pads	Alcohol Antiseptic Pads	72	27
Meclizine Hcl	Meclizine Hcl	72	40
Tramadol Hcl	Tramadol Hcl	55	17
Single Use Swab	Alcohol Antiseptic Pads	54	37
Breo Ellipta	Fluticasone/Vilanterol	52	21
Clopidogrel	Clopidogrel Bisulfate	52	17
Rybelsus	Semaglutide	52	18
Clotrimazole	Clotrimazole	51	19
Pravastatin Sodium	Pravastatin Sodium	50	14
Trulicity	Dulaglutide	49	14
Amitriptyline Hcl	Amitriptyline Hcl	43	13
Wixela Inhub	Fluticasone Propion/Salmeterol	43	14
Metoprolol Tartrate	Metoprolol Tartrate	42	17
Eliquis	Apixaban	41	19
Sildenafil Citrate	Sildenafil Citrate	40	17
Montelukast Sodium	Montelukast Sodium	39	17
Trazodone Hcl	Trazodone Hcl	35	14
Vitamin D2	Ergocalciferol (Vitamin D2)	34	20
Droplet Pen Needle	Pen Needle, Diabetic	33	12
Enalapril Maleate	Enalapril Maleate	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	18
Azelastine Hcl	Azelastine Hcl	32	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	28
Donepezil Hcl	Donepezil Hcl	30	12
Potassium Chloride	Potassium Chloride	30	suppressed
Fluconazole	Fluconazole	28	22
Duloxetine Hcl	Duloxetine Hcl	27	suppressed
Fenofibrate	Fenofibrate	27	suppressed
Prednisone	Prednisone	27	26
Triamcinolone Acetonide	Triamcinolone Acetonide	27	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	26	23
Clonidine Hcl	Clonidine Hcl	26	suppressed
Farxiga	Dapagliflozin Propanediol	26	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	26	suppressed
Sucralfate	Sucralfate	24	14
Valsartan	Valsartan	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	13
Solifenacin Succinate	Solifenacin Succinate	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	12
Irbesartan	Irbesartan	18	suppressed
Telmisartan	Telmisartan	18	suppressed
Fenofibrate	Fenofibrate,micronized	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Alprazolam	Alprazolam	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Dutasteride	Dutasteride	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Clarithromycin	Clarithromycin	14	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Ibuprofen	Ibuprofen	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	11
Torsemide	Torsemide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin	Amoxicillin	12	11
Bupropion Hcl	Bupropion Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Estradiol	Estradiol	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error